Aditya Bardia, MD
@dradityabardia
Medical Oncologist, UCLA. Passionate about accelerating innovative research and fostering academic mentorship to improve patient outcomes.
ID: 1697147768
https://www.uclahealth.org/news/internationally-renowned-oncologist-lead-breast-cancer 24-08-2013 18:29:37
1,1K Tweet
3,3K Followers
125 Following
Thank you to PMAC and the incredible mentors I have there including Massimo Cristofanilli, MD, FACP Aditya Bardia, MD Arielle Medford, MD Lorenzo Gerratana Carolina Reduzzi and many others, as well as Guardant Health for their support of this research. Find our rapid oral abstract here: meetings.asco.org/abstracts-pres…
.ESMO - Eur. Oncology recommendations for the use of NGS is published in Annals of Oncology . >200 references ! Breast cancer is one of the new indications. A special mention is done for tumor-agnostic indications. A big work from @fermosele and the precision medicine group of ESMO
Antibody Drug Conjugate, SG, enables sequential TOP1/PARP inhibitor strategy & highlights need to revisit previously abandoned combos with chemotherapy. Translational team collaboration Mass General Cancer Center Dana-Farber’s Breast Oncology Center #bcsm Full text Clinical Cancer Research aacrjournals.org/clincancerres/…
Javier Cortes MD PhD conclusions in EBC: 🤔 Carbo clearly needed in high risk TNBC, maybe we should try omitting anthracyclines now that we have immuno here. 👏 ISPY design of selecting size of therapy based on tumors response is a great way to personalize treatment #ASCO24 #bcsm
ISPY2.2 Dato-DXd + durvalumab beautifully presented by Rebecca Shatsky, MD. After 4 cycles neoadj Dato/durva, 4/42 pts w/ HR+ and 21/64 pts w/ HR- stage II/III EBC achieved pCR. 43% pCR in immune+ subtype, meeting graduation threshold. Grateful to participate in this innovate trial & to
Honored to participate in an ASCO OncLive.com Peer Direct panel on Advances in HR+ HER2- mBC with my esteemed colleagues Drs Hurvitz, Pegram and VIRGINIA KAKLAMANI. Go to OncLive.com to see our finished production. Thank you to organizers for the opportunity!
Congratulations Rachel Occhiogrosso Abelman, MD on the YIA and support from Conquer Cancer, the ASCO Foundation to continue the important work on ADC sequencing in MBC. #RisingStar
My old friend Aditya Bardia, MD and new friend Dr. Melissa Davis talking about breast cancer disparities at the Mass General Cancer Center 3rd Annual Cancer Equity Colloquium, running through tomorrow. Much work to do together.
Great work at Siteman Cancer Center and Fred & Pamela Buffett Cancer Center presented by Jairam Krishnamurthy and Dr. Nusayba Bagegni demonstrating that incomplete TKa suppression at C1D15 may identify pts with CDK 4/6i resistant tumors Two trials with DiviTum ongoing: clinicaltrials.gov/study/NCT04968… clinicaltrials.gov/study/NCT05977…
The DAVA Oncology 2024 #breastcancer Summit in beautiful 🏝️ #Kona, #Hawaii, was truly exceptional! 🌺 IMO, it was the most special #breastcancer meeting, where junior faculty had the unique opportunity to meet, network, and collaborate with the giants of breast oncology. Huge applause
